RxDoctor Payments Data
★ My doctorsLook up a doctor →

Patrick Denard, MD

Orthopaedic Surgery · Medford, ORNPI 1578684627

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $8,671,562 of the $11,531,845 with a category attached, or 75.2%. Arthrex accounts for 99.8% of it on its own, with 40 other manufacturers making up the rest. 2025 is the largest year on record at $2,909,265, 4.9 times the $596,332 reported in 2019. Among orthopaedic surgery clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,531,845in general payments, 2019–2025

Across 2,061 payments — averaging $5595.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$11.5M
  • Pacira Pharmaceuticals Incorporated$8K
  • Steelhead Surgical Inc$6K
  • Summit Surgical Corp.$404
  • Medwest Associates$384
  • Pylant Medical$348
  • plus $5K from 35 others
$1,511,289in research payments, 2019–2025

Across 148 payments — averaging $10,211 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Arthrex$1.5M
  • Encore Medical, LP$27K
  • Stryker$24K
$1,156,610in ownership & investment interests, 2019–2025

Across 1 payment — averaging $1,156,610 each. An ownership or investment interest held by the physician or an immediate family member.

  • Zurimed Technologies Inc.$1.2M

What the payments were for

  • Royalty or licence$8,671,56275%
  • Consulting fees$1,041,3769%
  • Speaking & faculty fees$1,603,06514%
  • Travel & lodging$186,8952%
  • Food & beverage$24,6760%
  • Education$4,2700%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Arthrex1,980$11,511,652
Pacira Pharmaceuticals Incorporated7$8,083
Steelhead Surgical Inc14$6,467
Summit Surgical Corp.4$404
Medwest Associates4$384
Pylant Medical4$348
Evolution Surgical, Inc2$325
Crossroads Orthopedics, LLC2$301
Conetic Solutions, Inc.4$242
Alpha Orthopedic Systems3$235
Reel Surgical, Inc.2$230
Encore Medical, LP1$230
Coastal Medical Technologies LLC1$170
Legacy Ortho LLC2$169
Team 1, LLC1$167
Rock Medical Orthopedics, Inc.1$164
Sioux Surgical Inc2$160
Prime Surgical, LLC1$156
Titan Surgical Group, LLC1$150
Suvon Surgical LLC1$148
Seapearl East, Inc1$145
FX Shoulder Solutions, Inc1$136
BREG, Inc1$135
Core Surgical Group1$131
Gemini Mountain Medical, LLC1$121
Fortis Surgical, LLC1$121
Peerless Surgical Inc.1$118
Mid-atlantic Surgical Systems, LLC1$117
Wardlow Enterprises1$117
Active Medical, LLC1$111
Supreme Orthopedic Systems, LLC1$103
Elite Orthopedics, LLC3$95
Foundation Medical, LLC1$46
Johnson & Johnson(2 entities)2$32
Zimmer Biomet1$27
Bioventus LLC1$22
Sanofi-aventis U.S. LLC1$21
Sequoia Surgical, Inc.1$18
Impactortho, Inc.1$17
Pinnacle, Inc1$17
Lightbody Medical Technologies Inc1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,531,845 in reported general payments places this provider in the 95th percentile of 228 orthopaedic surgery providers in Oregon.

See all orthopaedic surgery providers in Oregon →

Medicare billing

Part B allowed, 2024
$429,801
Medicare patients
502
Services billed
1,837

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone18$102
Oxycodone Hcl31$86
Ondansetron Hcl14$79
Meloxicam11$39
Gabapentin21$21

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Medford

See the full list for Oregon →

Where these figures come from

Is this you, or does something look wrong? →